	alt_sample_name	dataset	series	geo_accession	days_to_death	vital_status	er	her2	grade	T	N	treatment	chemo	tamoxifen	herceptin	age_at_initial_pathologic_diagnosis	tumor_size	characteristics_ch1.12	platform_id	supplementary_file	data_row_count	tissueGSM1415983	mcgill.gq.1	GSE58644	GSE58644	GSM1415983	44	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 45	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415983/GSM1415983.CEL.gz	32321	1GSM1415984	mcgill.gq.2	GSE58644	GSE58644	GSM1415984	143	event: 0	er: NA	her2: NA	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 66	size: 0.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415984/GSM1415984.CEL.gz	32321	1GSM1415985	mcgill.gq.3	GSE58644	GSE58644	GSM1415985	138	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 58	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415985/GSM1415985.CEL.gz	32321	1GSM1415986	mcgill.gq.4	GSE58644	GSE58644	GSM1415986	139	event: 0	er: 1	her2: 1	grade: 3	Stage: 1	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 53	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415986/GSM1415986.CEL.gz	32321	1GSM1415987	mcgill.gq.5	GSE58644	GSE58644	GSM1415987	86	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 70	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415987/GSM1415987.CEL.gz	32321	1GSM1415988	mcgill.gq.6	GSE58644	GSE58644	GSM1415988	93	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 49	size: 2.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415988/GSM1415988.CEL.gz	32321	1GSM1415989	mcgill.gq.7	GSE58644	GSE58644	GSM1415989	94	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 59	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415989/GSM1415989.CEL.gz	32321	1GSM1415990	mcgill.gq.8	GSE58644	GSE58644	GSM1415990	36	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 77	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415990/GSM1415990.CEL.gz	32321	1GSM1415991	mcgill.gq.9	GSE58644	GSE58644	GSM1415991	91	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 72	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415991/GSM1415991.CEL.gz	32321	1GSM1415992	mcgill.gq.10	GSE58644	GSE58644	GSM1415992	60	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 65	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415992/GSM1415992.CEL.gz	32321	1GSM1415993	mcgill.gq.11	GSE58644	GSE58644	GSM1415993	95	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 46	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415993/GSM1415993.CEL.gz	32321	1GSM1415994	mcgill.gq.12	GSE58644	GSE58644	GSM1415994	86	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 74	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415994/GSM1415994.CEL.gz	32321	1GSM1415995	mcgill.gq.13	GSE58644	GSE58644	GSM1415995	92	event: 0	er: 0	her2: 1	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 59	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415995/GSM1415995.CEL.gz	32321	1GSM1415996	mcgill.gq.14	GSE58644	GSE58644	GSM1415996	88	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 49	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415996/GSM1415996.CEL.gz	32321	1GSM1415997	mcgill.gq.15	GSE58644	GSE58644	GSM1415997	90	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 55	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415997/GSM1415997.CEL.gz	32321	1GSM1415998	mcgill.gq.16	GSE58644	GSE58644	GSM1415998	24	event: 1	er: 1	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 66	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415998/GSM1415998.CEL.gz	32321	1GSM1415999	mcgill.gq.17	GSE58644	GSE58644	GSM1415999	73	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 1	age: 55	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1415nnn/GSM1415999/GSM1415999.CEL.gz	32321	1GSM1416000	mcgill.gq.18	GSE58644	GSE58644	GSM1416000	118	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 64	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416000/GSM1416000.CEL.gz	32321	1GSM1416001	mcgill.gq.19	GSE58644	GSE58644	GSM1416001	41	event: 1	er: 1	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 39	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416001/GSM1416001.CEL.gz	32321	1GSM1416002	mcgill.gq.20	GSE58644	GSE58644	GSM1416002	5	event: 1	er: 1	her2: 0	grade: 3	Stage: 4	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 77	size: 5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416002/GSM1416002.CEL.gz	32321	1GSM1416003	mcgill.gq.21	GSE58644	GSE58644	GSM1416003	43	event: 0	er: 1	her2: 1	grade: 1	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 33	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416003/GSM1416003.CEL.gz	32321	1GSM1416004	mcgill.gq.22	GSE58644	GSE58644	GSM1416004	61	event: 1	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 65	size: 3.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416004/GSM1416004.CEL.gz	32321	1GSM1416005	mcgill.gq.23	GSE58644	GSE58644	GSM1416005	125	event: 1	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 44	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416005/GSM1416005.CEL.gz	32321	1GSM1416006	mcgill.gq.24	GSE58644	GSE58644	GSM1416006	135	event: 1	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 44	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416006/GSM1416006.CEL.gz	32321	1GSM1416007	mcgill.gq.25	GSE58644	GSE58644	GSM1416007	133	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 66	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416007/GSM1416007.CEL.gz	32321	1GSM1416008	mcgill.gq.26	GSE58644	GSE58644	GSM1416008	3	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 46	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416008/GSM1416008.CEL.gz	32321	1GSM1416009	mcgill.gq.27	GSE58644	GSE58644	GSM1416009	127	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 58	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416009/GSM1416009.CEL.gz	32321	1GSM1416010	mcgill.gq.28	GSE58644	GSE58644	GSM1416010	133	event: 0	er: 0	her2: 1	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 64	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416010/GSM1416010.CEL.gz	32321	1GSM1416011	mcgill.gq.29	GSE58644	GSE58644	GSM1416011	15	event: 1	er: 1	her2: 1	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 51	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416011/GSM1416011.CEL.gz	32321	1GSM1416012	mcgill.gq.30	GSE58644	GSE58644	GSM1416012	95	event: 0	er: 1	her2: 1	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 49	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416012/GSM1416012.CEL.gz	32321	1GSM1416013	mcgill.gq.31	GSE58644	GSE58644	GSM1416013	54	event: 0	er: 0	her2: 1	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 71	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416013/GSM1416013.CEL.gz	32321	1GSM1416014	mcgill.gq.32	GSE58644	GSE58644	GSM1416014	87	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 56	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416014/GSM1416014.CEL.gz	32321	1GSM1416015	mcgill.gq.33	GSE58644	GSE58644	GSM1416015	73	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 37	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416015/GSM1416015.CEL.gz	32321	1GSM1416016	mcgill.gq.34	GSE58644	GSE58644	GSM1416016	125	event: 0	er: 1	her2: 1	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 51	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416016/GSM1416016.CEL.gz	32321	1GSM1416017	mcgill.gq.35	GSE58644	GSE58644	GSM1416017	66	event: 1	er: 1	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 48	size: 9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416017/GSM1416017.CEL.gz	32321	1GSM1416018	mcgill.gq.36	GSE58644	GSE58644	GSM1416018	76	event: 0	er: 1	her2: 0	grade: 2	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 69	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416018/GSM1416018.CEL.gz	32321	1GSM1416019	mcgill.gq.37	GSE58644	GSE58644	GSM1416019	56	event: 1	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 53	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416019/GSM1416019.CEL.gz	32321	1GSM1416020	mcgill.gq.38	GSE58644	GSE58644	GSM1416020	139	event: 0	er: 1	her2: 0	grade: 1	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 53	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416020/GSM1416020.CEL.gz	32321	1GSM1416021	mcgill.gq.39	GSE58644	GSE58644	GSM1416021	26	event: 1	er: 1	her2: 1	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 77	size: 4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416021/GSM1416021.CEL.gz	32321	1GSM1416022	mcgill.gq.40	GSE58644	GSE58644	GSM1416022	17	event: 1	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 66	size: 0.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416022/GSM1416022.CEL.gz	32321	1GSM1416023	mcgill.gq.41	GSE58644	GSE58644	GSM1416023	126	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 56	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416023/GSM1416023.CEL.gz	32321	1GSM1416024	mcgill.gq.42	GSE58644	GSE58644	GSM1416024	105	event: 0	er: 0	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: NA	age: 35	size: 3.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416024/GSM1416024.CEL.gz	32321	1GSM1416025	mcgill.gq.43	GSE58644	GSE58644	GSM1416025	107	event: 0	er: 0	her2: 1	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 1	age: 45	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416025/GSM1416025.CEL.gz	32321	1GSM1416026	mcgill.gq.44	GSE58644	GSE58644	GSM1416026	12	event: 1	er: 0	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 55	size: 2.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416026/GSM1416026.CEL.gz	32321	1GSM1416027	mcgill.gq.45	GSE58644	GSE58644	GSM1416027	70	event: 0	er: 0	her2: 0	grade: 2	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 81	size: 9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416027/GSM1416027.CEL.gz	32321	1GSM1416028	mcgill.gq.46	GSE58644	GSE58644	GSM1416028	75	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 67	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416028/GSM1416028.CEL.gz	32321	1GSM1416029	mcgill.gq.47	GSE58644	GSE58644	GSM1416029	0	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: 0	age: 72	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416029/GSM1416029.CEL.gz	32321	1GSM1416030	mcgill.gq.48	GSE58644	GSE58644	GSM1416030	124	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 70	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416030/GSM1416030.CEL.gz	32321	1GSM1416031	mcgill.gq.49	GSE58644	GSE58644	GSM1416031	65	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: NA	herceptin: 0	age: 50	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416031/GSM1416031.CEL.gz	32321	1GSM1416032	mcgill.gq.50	GSE58644	GSE58644	GSM1416032	26	event: 1	er: 0	her2: 1	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 58	size: 7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416032/GSM1416032.CEL.gz	32321	1GSM1416033	mcgill.gq.51	GSE58644	GSE58644	GSM1416033	118	event: 0	er: 1	her2: 0	grade: 1	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 52	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416033/GSM1416033.CEL.gz	32321	1GSM1416034	mcgill.gq.52	GSE58644	GSE58644	GSM1416034	121	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 62	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416034/GSM1416034.CEL.gz	32321	1GSM1416035	mcgill.gq.53	GSE58644	GSE58644	GSM1416035	77	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 80	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416035/GSM1416035.CEL.gz	32321	1GSM1416036	mcgill.gq.54	GSE58644	GSE58644	GSM1416036	115	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 50	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416036/GSM1416036.CEL.gz	32321	1GSM1416037	mcgill.gq.55	GSE58644	GSE58644	GSM1416037	119	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 61	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416037/GSM1416037.CEL.gz	32321	1GSM1416038	mcgill.gq.56	GSE58644	GSE58644	GSM1416038	28	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 87	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416038/GSM1416038.CEL.gz	32321	1GSM1416039	mcgill.gq.57	GSE58644	GSE58644	GSM1416039	15	event: 1	er: 0	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 43	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416039/GSM1416039.CEL.gz	32321	1GSM1416040	mcgill.gq.58	GSE58644	GSE58644	GSM1416040	119	event: 0	er: 1	her2: 0	grade: 1	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 65	size: 0.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416040/GSM1416040.CEL.gz	32321	1GSM1416041	mcgill.gq.59	GSE58644	GSE58644	GSM1416041	50	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: 0	age: 75	size: 2.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416041/GSM1416041.CEL.gz	32321	1GSM1416042	mcgill.gq.60	GSE58644	GSE58644	GSM1416042	24	event: 1	er: 1	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 66	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416042/GSM1416042.CEL.gz	32321	1GSM1416043	mcgill.gq.61	GSE58644	GSE58644	GSM1416043	118	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 64	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416043/GSM1416043.CEL.gz	32321	1GSM1416044	mcgill.gq.62	GSE58644	GSE58644	GSM1416044	86	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 61	size: 1.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416044/GSM1416044.CEL.gz	32321	1GSM1416045	mcgill.gq.63	GSE58644	GSE58644	GSM1416045	80	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 50	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416045/GSM1416045.CEL.gz	32321	1GSM1416046	mcgill.gq.64	GSE58644	GSE58644	GSM1416046	77	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 70	size: 5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416046/GSM1416046.CEL.gz	32321	1GSM1416047	mcgill.gq.65	GSE58644	GSE58644	GSM1416047	111	event: 0	er: 1	her2: 1	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 66	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416047/GSM1416047.CEL.gz	32321	1GSM1416048	mcgill.gq.66	GSE58644	GSE58644	GSM1416048	26	event: 1	er: 1	her2: 1	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 51	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416048/GSM1416048.CEL.gz	32321	1GSM1416049	mcgill.gq.67	GSE58644	GSE58644	GSM1416049	26	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 46	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416049/GSM1416049.CEL.gz	32321	1GSM1416050	mcgill.gq.68	GSE58644	GSE58644	GSM1416050	62	event: 0	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 31	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416050/GSM1416050.CEL.gz	32321	1GSM1416051	mcgill.gq.69	GSE58644	GSE58644	GSM1416051	25	event: 1	er: 1	her2: 1	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 77	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416051/GSM1416051.CEL.gz	32321	1GSM1416052	mcgill.gq.70	GSE58644	GSE58644	GSM1416052	83	event: 0	er: 1	her2: 0	grade: 1	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 48	size: 1.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416052/GSM1416052.CEL.gz	32321	1GSM1416053	mcgill.gq.71	GSE58644	GSE58644	GSM1416053	116	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 45	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416053/GSM1416053.CEL.gz	32321	1GSM1416054	mcgill.gq.72	GSE58644	GSE58644	GSM1416054	103	event: 0	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 60	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416054/GSM1416054.CEL.gz	32321	1GSM1416055	mcgill.gq.73	GSE58644	GSE58644	GSM1416055	18	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 69	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416055/GSM1416055.CEL.gz	32321	1GSM1416056	mcgill.gq.74	GSE58644	GSE58644	GSM1416056	80	event: 0	er: 1	her2: 0	grade: 1	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 79	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416056/GSM1416056.CEL.gz	32321	1GSM1416057	mcgill.gq.75	GSE58644	GSE58644	GSM1416057	51	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 1	age: 49	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416057/GSM1416057.CEL.gz	32321	1GSM1416058	mcgill.gq.76	GSE58644	GSE58644	GSM1416058	18	event: 1	er: 0	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 55	size: 3.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416058/GSM1416058.CEL.gz	32321	1GSM1416059	mcgill.gq.77	GSE58644	GSE58644	GSM1416059	43	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 65	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416059/GSM1416059.CEL.gz	32321	1GSM1416060	mcgill.gq.78	GSE58644	GSE58644	GSM1416060	66	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 74	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416060/GSM1416060.CEL.gz	32321	1GSM1416061	mcgill.gq.79	GSE58644	GSE58644	GSM1416061	96	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 75	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416061/GSM1416061.CEL.gz	32321	1GSM1416062	mcgill.gq.80	GSE58644	GSE58644	GSM1416062	69	event: 1	er: 1	her2: 0	grade: 2	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 48	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416062/GSM1416062.CEL.gz	32321	1GSM1416063	mcgill.gq.81	GSE58644	GSE58644	GSM1416063	105	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 38	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416063/GSM1416063.CEL.gz	32321	1GSM1416064	mcgill.gq.82	GSE58644	GSE58644	GSM1416064	101	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 52	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416064/GSM1416064.CEL.gz	32321	1GSM1416065	mcgill.gq.83	GSE58644	GSE58644	GSM1416065	17	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 46	size: 3.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416065/GSM1416065.CEL.gz	32321	1GSM1416066	mcgill.gq.84	GSE58644	GSE58644	GSM1416066	106	event: 0	er: 1	her2: 1	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 58	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416066/GSM1416066.CEL.gz	32321	1GSM1416067	mcgill.gq.85	GSE58644	GSE58644	GSM1416067	104	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 67	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416067/GSM1416067.CEL.gz	32321	1GSM1416068	mcgill.gq.86	GSE58644	GSE58644	GSM1416068	7	event: 1	er: 1	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 83	size: 3.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416068/GSM1416068.CEL.gz	32321	1GSM1416069	mcgill.gq.87	GSE58644	GSE58644	GSM1416069	64	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 57	size: 4.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416069/GSM1416069.CEL.gz	32321	1GSM1416070	mcgill.gq.88	GSE58644	GSE58644	GSM1416070	100	event: 0	er: 0	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 40	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416070/GSM1416070.CEL.gz	32321	1GSM1416071	mcgill.gq.89	GSE58644	GSE58644	GSM1416071	105	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 62	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416071/GSM1416071.CEL.gz	32321	1GSM1416072	mcgill.gq.90	GSE58644	GSE58644	GSM1416072	108	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 57	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416072/GSM1416072.CEL.gz	32321	1GSM1416073	mcgill.gq.91	GSE58644	GSE58644	GSM1416073	23	event: 1	er: 0	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: NA	age: 57	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416073/GSM1416073.CEL.gz	32321	1GSM1416074	mcgill.gq.92	GSE58644	GSE58644	GSM1416074	78	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 43	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416074/GSM1416074.CEL.gz	32321	1GSM1416075	mcgill.gq.93	GSE58644	GSE58644	GSM1416075	52	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: NA	age: 83	size: 3.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416075/GSM1416075.CEL.gz	32321	1GSM1416076	mcgill.gq.94	GSE58644	GSE58644	GSM1416076	101	event: 0	er: 0	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: NA	age: 64	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416076/GSM1416076.CEL.gz	32321	1GSM1416077	mcgill.gq.95	GSE58644	GSE58644	GSM1416077	103	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: NA	age: 64	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416077/GSM1416077.CEL.gz	32321	1GSM1416078	mcgill.gq.96	GSE58644	GSE58644	GSM1416078	101	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: NA	age: 83	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416078/GSM1416078.CEL.gz	32321	1GSM1416079	mcgill.gq.97	GSE58644	GSE58644	GSM1416079	101	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 61	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416079/GSM1416079.CEL.gz	32321	1GSM1416080	mcgill.gq.98	GSE58644	GSE58644	GSM1416080	91	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 61	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416080/GSM1416080.CEL.gz	32321	1GSM1416081	mcgill.gq.99	GSE58644	GSE58644	GSM1416081	1	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 85	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416081/GSM1416081.CEL.gz	32321	1GSM1416082	mcgill.gq.100	GSE58644	GSE58644	GSM1416082	94	event: 0	er: 1	her2: 0	grade: 1	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 46	size: 0.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416082/GSM1416082.CEL.gz	32321	1GSM1416083	mcgill.gq.101	GSE58644	GSE58644	GSM1416083	88	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 50	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416083/GSM1416083.CEL.gz	32321	1GSM1416084	mcgill.gq.102	GSE58644	GSE58644	GSM1416084	89	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 46	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416084/GSM1416084.CEL.gz	32321	1GSM1416085	mcgill.gq.103	GSE58644	GSE58644	GSM1416085	80	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 72	size: 1.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416085/GSM1416085.CEL.gz	32321	1GSM1416086	mcgill.gq.104	GSE58644	GSE58644	GSM1416086	1	event: 1	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 47	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416086/GSM1416086.CEL.gz	32321	1GSM1416087	mcgill.gq.105	GSE58644	GSE58644	GSM1416087	96	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 38	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416087/GSM1416087.CEL.gz	32321	1GSM1416088	mcgill.gq.106	GSE58644	GSE58644	GSM1416088	46	event: 1	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 44	size: 1.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416088/GSM1416088.CEL.gz	32321	1GSM1416089	mcgill.gq.107	GSE58644	GSE58644	GSM1416089	103	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 73	size: 2.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416089/GSM1416089.CEL.gz	32321	1GSM1416090	mcgill.gq.108	GSE58644	GSE58644	GSM1416090	1	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 93	size: 4.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416090/GSM1416090.CEL.gz	32321	1GSM1416091	mcgill.gq.109	GSE58644	GSE58644	GSM1416091	105	event: 0	er: 0	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 56	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416091/GSM1416091.CEL.gz	32321	1GSM1416092	mcgill.gq.110	GSE58644	GSE58644	GSM1416092	6	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: NA	herceptin: 0	age: 72	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416092/GSM1416092.CEL.gz	32321	1GSM1416093	mcgill.gq.111	GSE58644	GSE58644	GSM1416093	67	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: NA	age: 41	size: 3.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416093/GSM1416093.CEL.gz	32321	1GSM1416094	mcgill.gq.112	GSE58644	GSE58644	GSM1416094	55	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: NA	age: 80	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416094/GSM1416094.CEL.gz	32321	1GSM1416095	mcgill.gq.113	GSE58644	GSE58644	GSM1416095	53	event: 0	er: 0	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 55	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416095/GSM1416095.CEL.gz	32321	1GSM1416096	mcgill.gq.114	GSE58644	GSE58644	GSM1416096	54	event: 0	er: 0	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 47	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416096/GSM1416096.CEL.gz	32321	1GSM1416097	mcgill.gq.115	GSE58644	GSE58644	GSM1416097	55	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 56	size: 3.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416097/GSM1416097.CEL.gz	32321	1GSM1416098	mcgill.gq.116	GSE58644	GSE58644	GSM1416098	2	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 45	size: 7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416098/GSM1416098.CEL.gz	32321	1GSM1416099	mcgill.gq.117	GSE58644	GSE58644	GSM1416099	77	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 44	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416099/GSM1416099.CEL.gz	32321	1GSM1416100	mcgill.gq.118	GSE58644	GSE58644	GSM1416100	27	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 76	size: 1.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416100/GSM1416100.CEL.gz	32321	1GSM1416101	mcgill.gq.119	GSE58644	GSE58644	GSM1416101	70	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: NA	age: 56	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416101/GSM1416101.CEL.gz	32321	1GSM1416102	mcgill.gq.120	GSE58644	GSE58644	GSM1416102	82	event: 0	er: 0	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 43	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416102/GSM1416102.CEL.gz	32321	1GSM1416103	mcgill.gq.121	GSE58644	GSE58644	GSM1416103	74	event: 0	er: 0	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 57	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416103/GSM1416103.CEL.gz	32321	1GSM1416104	mcgill.gq.122	GSE58644	GSE58644	GSM1416104	63	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 55	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416104/GSM1416104.CEL.gz	32321	1GSM1416105	mcgill.gq.123	GSE58644	GSE58644	GSM1416105	94	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 49	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416105/GSM1416105.CEL.gz	32321	1GSM1416106	mcgill.gq.124	GSE58644	GSE58644	GSM1416106	78	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 1	age: 43	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416106/GSM1416106.CEL.gz	32321	1GSM1416107	mcgill.gq.125	GSE58644	GSE58644	GSM1416107	4	event: 1	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 52	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416107/GSM1416107.CEL.gz	32321	1GSM1416108	mcgill.gq.126	GSE58644	GSE58644	GSM1416108	46	event: 0	er: 0	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 48	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416108/GSM1416108.CEL.gz	32321	1GSM1416109	mcgill.gq.127	GSE58644	GSE58644	GSM1416109	40	event: 0	er: 0	her2: 1	grade: 3	Stage: 1	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 56	size: 3.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416109/GSM1416109.CEL.gz	32321	1GSM1416110	mcgill.gq.128	GSE58644	GSE58644	GSM1416110	37	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 41	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416110/GSM1416110.CEL.gz	32321	1GSM1416111	mcgill.gq.129	GSE58644	GSE58644	GSM1416111	18	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 62	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416111/GSM1416111.CEL.gz	32321	1GSM1416112	mcgill.gq.130	GSE58644	GSE58644	GSM1416112	38	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 64	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416112/GSM1416112.CEL.gz	32321	1GSM1416113	mcgill.gq.131	GSE58644	GSE58644	GSM1416113	24	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 55	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416113/GSM1416113.CEL.gz	32321	1GSM1416114	mcgill.gq.132	GSE58644	GSE58644	GSM1416114	40	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 44	size: 6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416114/GSM1416114.CEL.gz	32321	1GSM1416115	mcgill.gq.133	GSE58644	GSE58644	GSM1416115	9	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 81	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416115/GSM1416115.CEL.gz	32321	1GSM1416116	mcgill.gq.134	GSE58644	GSE58644	GSM1416116	41	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 46	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416116/GSM1416116.CEL.gz	32321	1GSM1416117	mcgill.gq.135	GSE58644	GSE58644	GSM1416117	39	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: 1	herceptin: 0	age: 48	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416117/GSM1416117.CEL.gz	32321	1GSM1416118	mcgill.gq.136	GSE58644	GSE58644	GSM1416118	24	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 75	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416118/GSM1416118.CEL.gz	32321	1GSM1416119	mcgill.gq.137	GSE58644	GSE58644	GSM1416119	13	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 90	size: 3.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416119/GSM1416119.CEL.gz	32321	1GSM1416120	mcgill.gq.138	GSE58644	GSE58644	GSM1416120	26	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 60	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416120/GSM1416120.CEL.gz	32321	1GSM1416121	mcgill.gq.139	GSE58644	GSE58644	GSM1416121	19	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 63	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416121/GSM1416121.CEL.gz	32321	1GSM1416122	mcgill.gq.140	GSE58644	GSE58644	GSM1416122	2	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 48	size: 4.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416122/GSM1416122.CEL.gz	32321	1GSM1416123	mcgill.gq.141	GSE58644	GSE58644	GSM1416123	17	event: 1	er: 0	her2: 0	grade: 3	Stage: 1	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: 0	age: 64	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416123/GSM1416123.CEL.gz	32321	1GSM1416124	mcgill.gq.142	GSE58644	GSE58644	GSM1416124	19	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 74	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416124/GSM1416124.CEL.gz	32321	1GSM1416125	mcgill.gq.143	GSE58644	GSE58644	GSM1416125	0	event: 0	er: 0	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 54	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416125/GSM1416125.CEL.gz	32321	1GSM1416126	mcgill.gq.144	GSE58644	GSE58644	GSM1416126	6	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 38	size: 6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416126/GSM1416126.CEL.gz	32321	1GSM1416127	mcgill.gq.145	GSE58644	GSE58644	GSM1416127	27	event: 1	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 51	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416127/GSM1416127.CEL.gz	32321	1GSM1416128	mcgill.gq.146	GSE58644	GSE58644	GSM1416128	21	event: 1	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 66	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416128/GSM1416128.CEL.gz	32321	1GSM1416129	mcgill.gq.147	GSE58644	GSE58644	GSM1416129	80	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 67	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416129/GSM1416129.CEL.gz	32321	1GSM1416130	mcgill.gq.148	GSE58644	GSE58644	GSM1416130	79	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 62	size: 2.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416130/GSM1416130.CEL.gz	32321	1GSM1416131	mcgill.gq.149	GSE58644	GSE58644	GSM1416131	69	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 58	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416131/GSM1416131.CEL.gz	32321	1GSM1416132	mcgill.gq.150	GSE58644	GSE58644	GSM1416132	73	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 29	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416132/GSM1416132.CEL.gz	32321	1GSM1416133	mcgill.gq.151	GSE58644	GSE58644	GSM1416133	62	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 46	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416133/GSM1416133.CEL.gz	32321	1GSM1416134	mcgill.gq.152	GSE58644	GSE58644	GSM1416134	52	event: 0	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 49	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416134/GSM1416134.CEL.gz	32321	1GSM1416135	mcgill.gq.153	GSE58644	GSE58644	GSM1416135	34	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 74	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416135/GSM1416135.CEL.gz	32321	1GSM1416136	mcgill.gq.154	GSE58644	GSE58644	GSM1416136	11	event: 1	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 79	size: 2.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416136/GSM1416136.CEL.gz	32321	1GSM1416137	mcgill.gq.155	GSE58644	GSE58644	GSM1416137	23	event: 0	er: 0	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 48	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416137/GSM1416137.CEL.gz	32321	1GSM1416138	mcgill.gq.156	GSE58644	GSE58644	GSM1416138	17	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 38	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416138/GSM1416138.CEL.gz	32321	1GSM1416139	mcgill.gq.157	GSE58644	GSE58644	GSM1416139	38	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 39	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416139/GSM1416139.CEL.gz	32321	1GSM1416140	mcgill.gq.158	GSE58644	GSE58644	GSM1416140	41	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 59	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416140/GSM1416140.CEL.gz	32321	1GSM1416141	mcgill.gq.159	GSE58644	GSE58644	GSM1416141	30	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 89	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416141/GSM1416141.CEL.gz	32321	1GSM1416142	mcgill.gq.160	GSE58644	GSE58644	GSM1416142	37	event: 0	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 64	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416142/GSM1416142.CEL.gz	32321	1GSM1416143	mcgill.gq.161	GSE58644	GSE58644	GSM1416143	27	event: 0	er: 1	her2: 1	grade: 2	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 31	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416143/GSM1416143.CEL.gz	32321	1GSM1416144	mcgill.gq.162	GSE58644	GSE58644	GSM1416144	34	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 51	size: 3.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416144/GSM1416144.CEL.gz	32321	1GSM1416145	mcgill.gq.163	GSE58644	GSE58644	GSM1416145	83	event: 0	er: 1	her2: NA	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 44	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416145/GSM1416145.CEL.gz	32321	1GSM1416146	mcgill.gq.164	GSE58644	GSE58644	GSM1416146	75	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 66	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416146/GSM1416146.CEL.gz	32321	1GSM1416147	mcgill.gq.165	GSE58644	GSE58644	GSM1416147	10	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 78	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416147/GSM1416147.CEL.gz	32321	1GSM1416148	mcgill.gq.166	GSE58644	GSE58644	GSM1416148	36	event: 0	er: 1	her2: 1	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 59	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416148/GSM1416148.CEL.gz	32321	1GSM1416149	mcgill.gq.167	GSE58644	GSE58644	GSM1416149	38	event: 0	er: 1	her2: 0	grade: 1	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 63	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416149/GSM1416149.CEL.gz	32321	1GSM1416150	mcgill.gq.168	GSE58644	GSE58644	GSM1416150	14	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 76	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416150/GSM1416150.CEL.gz	32321	1GSM1416151	mcgill.gq.169	GSE58644	GSE58644	GSM1416151	17	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 73	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416151/GSM1416151.CEL.gz	32321	1GSM1416152	mcgill.gq.170	GSE58644	GSE58644	GSM1416152	64	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 59	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416152/GSM1416152.CEL.gz	32321	1GSM1416153	mcgill.gq.171	GSE58644	GSE58644	GSM1416153	96	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 75	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416153/GSM1416153.CEL.gz	32321	1GSM1416154	mcgill.gq.172	GSE58644	GSE58644	GSM1416154	27	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 72	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416154/GSM1416154.CEL.gz	32321	1GSM1416155	mcgill.gq.173	GSE58644	GSE58644	GSM1416155	36	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 85	size: 6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416155/GSM1416155.CEL.gz	32321	1GSM1416156	mcgill.gq.174	GSE58644	GSE58644	GSM1416156	43	event: 0	er: 0	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 34	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416156/GSM1416156.CEL.gz	32321	1GSM1416157	mcgill.gq.175	GSE58644	GSE58644	GSM1416157	33	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 60	size: 3.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416157/GSM1416157.CEL.gz	32321	1GSM1416158	mcgill.gq.176	GSE58644	GSE58644	GSM1416158	21	event: 1	er: 1	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 74	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416158/GSM1416158.CEL.gz	32321	1GSM1416159	mcgill.gq.177	GSE58644	GSE58644	GSM1416159	14	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 47	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416159/GSM1416159.CEL.gz	32321	1GSM1416160	mcgill.gq.178	GSE58644	GSE58644	GSM1416160	96	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 50	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416160/GSM1416160.CEL.gz	32321	1GSM1416161	mcgill.gq.179	GSE58644	GSE58644	GSM1416161	12	event: 1	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 39	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416161/GSM1416161.CEL.gz	32321	1GSM1416162	mcgill.gq.180	GSE58644	GSE58644	GSM1416162	26	event: 1	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 81	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416162/GSM1416162.CEL.gz	32321	1GSM1416163	mcgill.gq.181	GSE58644	GSE58644	GSM1416163	52	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 74	size: 2.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416163/GSM1416163.CEL.gz	32321	1GSM1416164	mcgill.gq.182	GSE58644	GSE58644	GSM1416164	103	event: 0	er: 1	her2: 0	grade: 3	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 47	size: 4.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416164/GSM1416164.CEL.gz	32321	1GSM1416165	mcgill.gq.183	GSE58644	GSE58644	GSM1416165	86	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 44	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416165/GSM1416165.CEL.gz	32321	1GSM1416166	mcgill.gq.184	GSE58644	GSE58644	GSM1416166	82	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 60	size: 2.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416166/GSM1416166.CEL.gz	32321	1GSM1416167	mcgill.gq.185	GSE58644	GSE58644	GSM1416167	39	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 57	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416167/GSM1416167.CEL.gz	32321	1GSM1416168	mcgill.gq.186	GSE58644	GSE58644	GSM1416168	74	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 39	size: 2.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416168/GSM1416168.CEL.gz	32321	1GSM1416169	mcgill.gq.187	GSE58644	GSE58644	GSM1416169	75	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 70	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416169/GSM1416169.CEL.gz	32321	1GSM1416170	mcgill.gq.188	GSE58644	GSE58644	GSM1416170	26	event: 1	er: 0	her2: 0	grade: 3	Stage: 3	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 34	size: 3.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416170/GSM1416170.CEL.gz	32321	1GSM1416171	mcgill.gq.189	GSE58644	GSE58644	GSM1416171	13	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 60	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416171/GSM1416171.CEL.gz	32321	1GSM1416172	mcgill.gq.190	GSE58644	GSE58644	GSM1416172	14	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 54	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416172/GSM1416172.CEL.gz	32321	1GSM1416173	mcgill.gq.191	GSE58644	GSE58644	GSM1416173	43	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 79	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416173/GSM1416173.CEL.gz	32321	1GSM1416174	mcgill.gq.192	GSE58644	GSE58644	GSM1416174	51	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 64	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416174/GSM1416174.CEL.gz	32321	1GSM1416175	mcgill.gq.193	GSE58644	GSE58644	GSM1416175	37	event: 0	er: 1	her2: 0	grade: 1	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 39	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416175/GSM1416175.CEL.gz	32321	1GSM1416176	mcgill.gq.194	GSE58644	GSE58644	GSM1416176	48	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 50	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416176/GSM1416176.CEL.gz	32321	1GSM1416177	mcgill.gq.195	GSE58644	GSE58644	GSM1416177	141	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 73	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416177/GSM1416177.CEL.gz	32321	1GSM1416178	mcgill.gq.196	GSE58644	GSE58644	GSM1416178	50	event: 0	er: 1	her2: NA	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 58	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416178/GSM1416178.CEL.gz	32321	1GSM1416179	mcgill.gq.197	GSE58644	GSE58644	GSM1416179	70	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 46	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416179/GSM1416179.CEL.gz	32321	1GSM1416180	mcgill.gq.198	GSE58644	GSE58644	GSM1416180	92	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 55	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416180/GSM1416180.CEL.gz	32321	1GSM1416181	mcgill.gq.199	GSE58644	GSE58644	GSM1416181	115	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 89	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416181/GSM1416181.CEL.gz	32321	1GSM1416182	mcgill.gq.200	GSE58644	GSE58644	GSM1416182	13	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 50	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416182/GSM1416182.CEL.gz	32321	1GSM1416183	mcgill.gq.201	GSE58644	GSE58644	GSM1416183	64	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 69	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416183/GSM1416183.CEL.gz	32321	1GSM1416184	mcgill.gq.202	GSE58644	GSE58644	GSM1416184	110	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 37	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416184/GSM1416184.CEL.gz	32321	1GSM1416185	mcgill.gq.203	GSE58644	GSE58644	GSM1416185	47	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 52	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416185/GSM1416185.CEL.gz	32321	1GSM1416186	mcgill.gq.204	GSE58644	GSE58644	GSM1416186	29	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 63	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416186/GSM1416186.CEL.gz	32321	1GSM1416187	mcgill.gq.205	GSE58644	GSE58644	GSM1416187	39	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 62	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416187/GSM1416187.CEL.gz	32321	1GSM1416188	mcgill.gq.206	GSE58644	GSE58644	GSM1416188	15	event: 1	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 52	size: 4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416188/GSM1416188.CEL.gz	32321	1GSM1416189	mcgill.gq.207	GSE58644	GSE58644	GSM1416189	40	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 52	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416189/GSM1416189.CEL.gz	32321	1GSM1416190	mcgill.gq.208	GSE58644	GSE58644	GSM1416190	35	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 44	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416190/GSM1416190.CEL.gz	32321	1GSM1416191	mcgill.gq.209	GSE58644	GSE58644	GSM1416191	34	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 75	size: 1.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416191/GSM1416191.CEL.gz	32321	1GSM1416192	mcgill.gq.210	GSE58644	GSE58644	GSM1416192	38	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 58	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416192/GSM1416192.CEL.gz	32321	1GSM1416193	mcgill.gq.211	GSE58644	GSE58644	GSM1416193	34	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 48	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416193/GSM1416193.CEL.gz	32321	1GSM1416194	mcgill.gq.212	GSE58644	GSE58644	GSM1416194	10	event: 1	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 50	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416194/GSM1416194.CEL.gz	32321	1GSM1416195	mcgill.gq.213	GSE58644	GSE58644	GSM1416195	33	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 41	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416195/GSM1416195.CEL.gz	32321	1GSM1416196	mcgill.gq.214	GSE58644	GSE58644	GSM1416196	35	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 65	size: 2.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416196/GSM1416196.CEL.gz	32321	1GSM1416197	mcgill.gq.215	GSE58644	GSE58644	GSM1416197	36	event: 0	er: 1	her2: NA	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 60	size: 6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416197/GSM1416197.CEL.gz	32321	1GSM1416198	mcgill.gq.216	GSE58644	GSE58644	GSM1416198	69	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 72	size: 3.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416198/GSM1416198.CEL.gz	32321	1GSM1416199	mcgill.gq.217	GSE58644	GSE58644	GSM1416199	92	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 40	size: 4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416199/GSM1416199.CEL.gz	32321	1GSM1416200	mcgill.gq.218	GSE58644	GSE58644	GSM1416200	35	event: 0	er: 0	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 68	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416200/GSM1416200.CEL.gz	32321	1GSM1416201	mcgill.gq.219	GSE58644	GSE58644	GSM1416201	9	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 56	size: 2.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416201/GSM1416201.CEL.gz	32321	1GSM1416202	mcgill.gq.220	GSE58644	GSE58644	GSM1416202	37	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 51	size: 15	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416202/GSM1416202.CEL.gz	32321	1GSM1416203	mcgill.gq.221	GSE58644	GSE58644	GSM1416203	14	event: 1	er: 1	her2: 0	grade: 1	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 81	size: 1.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416203/GSM1416203.CEL.gz	32321	1GSM1416204	mcgill.gq.222	GSE58644	GSE58644	GSM1416204	35	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 43	size: 4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416204/GSM1416204.CEL.gz	32321	1GSM1416205	mcgill.gq.223	GSE58644	GSE58644	GSM1416205	29	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 50	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416205/GSM1416205.CEL.gz	32321	1GSM1416206	mcgill.gq.224	GSE58644	GSE58644	GSM1416206	31	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 60	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416206/GSM1416206.CEL.gz	32321	1GSM1416207	mcgill.gq.225	GSE58644	GSE58644	GSM1416207	31	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 73	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416207/GSM1416207.CEL.gz	32321	1GSM1416208	mcgill.gq.226	GSE58644	GSE58644	GSM1416208	33	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 65	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416208/GSM1416208.CEL.gz	32321	1GSM1416209	mcgill.gq.227	GSE58644	GSE58644	GSM1416209	27	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 75	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416209/GSM1416209.CEL.gz	32321	1GSM1416210	mcgill.gq.228	GSE58644	GSE58644	GSM1416210	29	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 66	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416210/GSM1416210.CEL.gz	32321	1GSM1416211	mcgill.gq.229	GSE58644	GSE58644	GSM1416211	19	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 0	herceptin: 0	age: 66	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416211/GSM1416211.CEL.gz	32321	1GSM1416212	mcgill.gq.230	GSE58644	GSE58644	GSM1416212	123	event: 0	er: 0	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 58	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416212/GSM1416212.CEL.gz	32321	1GSM1416213	mcgill.gq.231	GSE58644	GSE58644	GSM1416213	36	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 47	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416213/GSM1416213.CEL.gz	32321	1GSM1416214	mcgill.gq.232	GSE58644	GSE58644	GSM1416214	94	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 63	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416214/GSM1416214.CEL.gz	32321	1GSM1416215	mcgill.gq.233	GSE58644	GSE58644	GSM1416215	29	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 49	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416215/GSM1416215.CEL.gz	32321	1GSM1416216	mcgill.gq.234	GSE58644	GSE58644	GSM1416216	2	event: NA	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 47	size: 1.3	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416216/GSM1416216.CEL.gz	32321	1GSM1416217	mcgill.gq.235	GSE58644	GSE58644	GSM1416217	26	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 57	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416217/GSM1416217.CEL.gz	32321	1GSM1416218	mcgill.gq.236	GSE58644	GSE58644	GSM1416218	28	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 62	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416218/GSM1416218.CEL.gz	32321	1GSM1416219	mcgill.gq.237	GSE58644	GSE58644	GSM1416219	26	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 73	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416219/GSM1416219.CEL.gz	32321	1GSM1416220	mcgill.gq.238	GSE58644	GSE58644	GSM1416220	33	event: 0	er: 1	her2: NA	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 64	size: 3.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416220/GSM1416220.CEL.gz	32321	1GSM1416221	mcgill.gq.239	GSE58644	GSE58644	GSM1416221	27	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 53	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416221/GSM1416221.CEL.gz	32321	1GSM1416222	mcgill.gq.240	GSE58644	GSE58644	GSM1416222	27	event: 0	er: 1	her2: NA	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 48	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416222/GSM1416222.CEL.gz	32321	1GSM1416223	mcgill.gq.241	GSE58644	GSE58644	GSM1416223	25	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 47	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416223/GSM1416223.CEL.gz	32321	1GSM1416224	mcgill.gq.242	GSE58644	GSE58644	GSM1416224	28	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 42	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416224/GSM1416224.CEL.gz	32321	1GSM1416225	mcgill.gq.243	GSE58644	GSE58644	GSM1416225	26	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 57	size: 2.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416225/GSM1416225.CEL.gz	32321	1GSM1416226	mcgill.gq.244	GSE58644	GSE58644	GSM1416226	24	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 63	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416226/GSM1416226.CEL.gz	32321	1GSM1416227	mcgill.gq.245	GSE58644	GSE58644	GSM1416227	26	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 50	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416227/GSM1416227.CEL.gz	32321	1GSM1416228	mcgill.gq.246	GSE58644	GSE58644	GSM1416228	33	event: NA	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 51	size: 2	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416228/GSM1416228.CEL.gz	32321	1GSM1416229	mcgill.gq.247	GSE58644	GSE58644	GSM1416229	81	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 61	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416229/GSM1416229.CEL.gz	32321	1GSM1416230	mcgill.gq.248	GSE58644	GSE58644	GSM1416230	0	event: NA	er: 1	her2: 1	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 80	size: 4	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416230/GSM1416230.CEL.gz	32321	1GSM1416231	mcgill.gq.249	GSE58644	GSE58644	GSM1416231	11	event: 1	er: 1	her2: 0	grade: 1	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 81	size: 1.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416231/GSM1416231.CEL.gz	32321	1GSM1416232	mcgill.gq.250	GSE58644	GSE58644	GSM1416232	30	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 0	herceptin: 0	age: 52	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416232/GSM1416232.CEL.gz	32321	1GSM1416233	mcgill.gq.251	GSE58644	GSE58644	GSM1416233	97	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 1	age: 71	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416233/GSM1416233.CEL.gz	32321	1GSM1416234	mcgill.gq.252	GSE58644	GSE58644	GSM1416234	23	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 77	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416234/GSM1416234.CEL.gz	32321	1GSM1416235	mcgill.gq.253	GSE58644	GSE58644	GSM1416235	97	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 69	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416235/GSM1416235.CEL.gz	32321	1GSM1416236	mcgill.gq.254	GSE58644	GSE58644	GSM1416236	89	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 46	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416236/GSM1416236.CEL.gz	32321	1GSM1416237	mcgill.gq.255	GSE58644	GSE58644	GSM1416237	84	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 83	size: 3.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416237/GSM1416237.CEL.gz	32321	1GSM1416238	mcgill.gq.256	GSE58644	GSE58644	GSM1416238	60	event: NA	er: 1	her2: 1	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 56	size: 2.5	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416238/GSM1416238.CEL.gz	32321	1GSM1416239	mcgill.gq.257	GSE58644	GSE58644	GSM1416239	27	event: 1	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 51	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416239/GSM1416239.CEL.gz	32321	1GSM1416240	mcgill.gq.258	GSE58644	GSE58644	GSM1416240	24	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 64	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416240/GSM1416240.CEL.gz	32321	1GSM1416241	mcgill.gq.259	GSE58644	GSE58644	GSM1416241	24	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 75	size: 4.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416241/GSM1416241.CEL.gz	32321	1GSM1416242	mcgill.gq.260	GSE58644	GSE58644	GSM1416242	22	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 52	size: 1.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416242/GSM1416242.CEL.gz	32321	1GSM1416243	mcgill.gq.261	GSE58644	GSE58644	GSM1416243	78	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 79	size: 1.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416243/GSM1416243.CEL.gz	32321	1GSM1416244	mcgill.gq.262	GSE58644	GSE58644	GSM1416244	41	event: 0	er: 1	her2: 0	grade: 1	Stage: 1	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 81	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416244/GSM1416244.CEL.gz	32321	1GSM1416245	mcgill.gq.263	GSE58644	GSE58644	GSM1416245	38	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 57	size: 5.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416245/GSM1416245.CEL.gz	32321	1GSM1416246	mcgill.gq.264	GSE58644	GSE58644	GSM1416246	11	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 69	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416246/GSM1416246.CEL.gz	32321	1GSM1416247	mcgill.gq.265	GSE58644	GSE58644	GSM1416247	19	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 34	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416247/GSM1416247.CEL.gz	32321	1GSM1416248	mcgill.gq.266	GSE58644	GSE58644	GSM1416248	26	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 35	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416248/GSM1416248.CEL.gz	32321	1GSM1416249	mcgill.gq.267	GSE58644	GSE58644	GSM1416249	116	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 63	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416249/GSM1416249.CEL.gz	32321	1GSM1416250	mcgill.gq.268	GSE58644	GSE58644	GSM1416250	121	event: 0	er: 1	her2: 0	grade: 3	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 64	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416250/GSM1416250.CEL.gz	32321	1GSM1416251	mcgill.gq.269	GSE58644	GSE58644	GSM1416251	116	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 71	size: 1.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416251/GSM1416251.CEL.gz	32321	1GSM1416252	mcgill.gq.270	GSE58644	GSE58644	GSM1416252	109	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 82	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416252/GSM1416252.CEL.gz	32321	1GSM1416253	mcgill.gq.271	GSE58644	GSE58644	GSM1416253	23	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 75	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416253/GSM1416253.CEL.gz	32321	1GSM1416254	mcgill.gq.272	GSE58644	GSE58644	GSM1416254	21	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 74	size: 3.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416254/GSM1416254.CEL.gz	32321	1GSM1416255	mcgill.gq.273	GSE58644	GSE58644	GSM1416255	20	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: NA	tamoxifen: NA	herceptin: NA	age: 69	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416255/GSM1416255.CEL.gz	32321	1GSM1416256	mcgill.gq.274	GSE58644	GSE58644	GSM1416256	6	event: 1	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 1	age: 35	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416256/GSM1416256.CEL.gz	32321	1GSM1416257	mcgill.gq.275	GSE58644	GSE58644	GSM1416257	100	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 63	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416257/GSM1416257.CEL.gz	32321	1GSM1416258	mcgill.gq.276	GSE58644	GSE58644	GSM1416258	75	event: 0	er: 0	her2: 1	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 64	size: 2.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416258/GSM1416258.CEL.gz	32321	1GSM1416259	mcgill.gq.277	GSE58644	GSE58644	GSM1416259	25	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 56	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416259/GSM1416259.CEL.gz	32321	1GSM1416260	mcgill.gq.278	GSE58644	GSE58644	GSM1416260	23	event: 0	er: 1	her2: NA	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 73	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416260/GSM1416260.CEL.gz	32321	1GSM1416261	mcgill.gq.279	GSE58644	GSE58644	GSM1416261	22	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 47	size: 4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416261/GSM1416261.CEL.gz	32321	1GSM1416262	mcgill.gq.280	GSE58644	GSE58644	GSM1416262	140	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 60	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416262/GSM1416262.CEL.gz	32321	1GSM1416263	mcgill.gq.281	GSE58644	GSE58644	GSM1416263	142	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 49	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416263/GSM1416263.CEL.gz	32321	1GSM1416264	mcgill.gq.282	GSE58644	GSE58644	GSM1416264	138	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 48	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416264/GSM1416264.CEL.gz	32321	1GSM1416265	mcgill.gq.283	GSE58644	GSE58644	GSM1416265	120	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 49	size: 1.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416265/GSM1416265.CEL.gz	32321	1GSM1416266	mcgill.gq.284	GSE58644	GSE58644	GSM1416266	119	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 57	size: 0.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416266/GSM1416266.CEL.gz	32321	1GSM1416267	mcgill.gq.285	GSE58644	GSE58644	GSM1416267	104	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 54	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416267/GSM1416267.CEL.gz	32321	1GSM1416268	mcgill.gq.286	GSE58644	GSE58644	GSM1416268	90	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 59	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416268/GSM1416268.CEL.gz	32321	1GSM1416269	mcgill.gq.287	GSE58644	GSE58644	GSM1416269	132	event: 0	er: 0	her2: 1	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 34	size: 0.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416269/GSM1416269.CEL.gz	32321	1GSM1416270	mcgill.gq.288	GSE58644	GSE58644	GSM1416270	41	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 60	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416270/GSM1416270.CEL.gz	32321	1GSM1416271	mcgill.gq.289	GSE58644	GSE58644	GSM1416271	64	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 85	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416271/GSM1416271.CEL.gz	32321	1GSM1416272	mcgill.gq.290	GSE58644	GSE58644	GSM1416272	117	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 51	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416272/GSM1416272.CEL.gz	32321	1GSM1416273	mcgill.gq.291	GSE58644	GSE58644	GSM1416273	105	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 41	size: 2.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416273/GSM1416273.CEL.gz	32321	1GSM1416274	mcgill.gq.292	GSE58644	GSE58644	GSM1416274	14	event: NA	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 56	size: 2	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416274/GSM1416274.CEL.gz	32321	1GSM1416275	mcgill.gq.293	GSE58644	GSE58644	GSM1416275	45	event: NA	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 83	size: 1.6	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416275/GSM1416275.CEL.gz	32321	1GSM1416276	mcgill.gq.294	GSE58644	GSE58644	GSM1416276	72	event: NA	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 39	size: 2.7	suderman.et.al: 0	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416276/GSM1416276.CEL.gz	32321	1GSM1416277	mcgill.gq.295	GSE58644	GSE58644	GSM1416277	16	event: 1	er: 0	her2: 1	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: 0	age: 65	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416277/GSM1416277.CEL.gz	32321	1GSM1416278	mcgill.gq.296	GSE58644	GSE58644	GSM1416278	102	event: 1	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 79	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416278/GSM1416278.CEL.gz	32321	1GSM1416279	mcgill.gq.297	GSE58644	GSE58644	GSM1416279	102	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 45	size: 2.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416279/GSM1416279.CEL.gz	32321	1GSM1416280	mcgill.gq.298	GSE58644	GSE58644	GSM1416280	26	event: 0	er: 1	her2: 0	grade: 1	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: 0	age: 80	size: 1.3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416280/GSM1416280.CEL.gz	32321	1GSM1416281	mcgill.gq.299	GSE58644	GSE58644	GSM1416281	42	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: 0	age: 51	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416281/GSM1416281.CEL.gz	32321	1GSM1416282	mcgill.gq.300	GSE58644	GSE58644	GSM1416282	26	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 58	size: 1.8	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416282/GSM1416282.CEL.gz	32321	1GSM1416283	mcgill.gq.301	GSE58644	GSE58644	GSM1416283	23	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 57	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416283/GSM1416283.CEL.gz	32321	1GSM1416284	mcgill.gq.302	GSE58644	GSE58644	GSM1416284	23	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 53	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416284/GSM1416284.CEL.gz	32321	1GSM1416285	mcgill.gq.303	GSE58644	GSE58644	GSM1416285	23	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 57	size: 2.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416285/GSM1416285.CEL.gz	32321	1GSM1416286	mcgill.gq.304	GSE58644	GSE58644	GSM1416286	24	event: 0	er: 1	her2: 0	grade: 3	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 61	size: 1.4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416286/GSM1416286.CEL.gz	32321	1GSM1416287	mcgill.gq.305	GSE58644	GSE58644	GSM1416287	20	event: 0	er: 1	her2: 0	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 81	size: 4	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416287/GSM1416287.CEL.gz	32321	1GSM1416288	mcgill.gq.306	GSE58644	GSE58644	GSM1416288	28	event: 1	er: 1	her2: 0	grade: 2	Stage: NA	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 50	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416288/GSM1416288.CEL.gz	32321	1GSM1416289	mcgill.gq.307	GSE58644	GSE58644	GSM1416289	25	event: 0	er: 1	her2: 1	grade: 2	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 66	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416289/GSM1416289.CEL.gz	32321	1GSM1416290	mcgill.gq.308	GSE58644	GSE58644	GSM1416290	24	event: 0	er: 1	her2: 1	grade: 3	Stage: NA	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 50	size: 1.7	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416290/GSM1416290.CEL.gz	32321	1GSM1416291	mcgill.gq.309	GSE58644	GSE58644	GSM1416291	135	event: 1	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 64	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416291/GSM1416291.CEL.gz	32321	1GSM1416292	mcgill.gq.310	GSE58644	GSE58644	GSM1416292	86	event: 1	er: 1	her2: 1	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 54	size: 2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416292/GSM1416292.CEL.gz	32321	1GSM1416293	mcgill.gq.311	GSE58644	GSE58644	GSM1416293	144	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 54	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416293/GSM1416293.CEL.gz	32321	1GSM1416294	mcgill.gq.312	GSE58644	GSE58644	GSM1416294	141	event: 0	er: 0	her2: 1	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: NA	herceptin: NA	age: 58	size: 2.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416294/GSM1416294.CEL.gz	32321	1GSM1416295	mcgill.gq.313	GSE58644	GSE58644	GSM1416295	73	event: 0	er: 1	her2: 0	grade: 2	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 42	size: 1.9	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416295/GSM1416295.CEL.gz	32321	1GSM1416296	mcgill.gq.314	GSE58644	GSE58644	GSM1416296	131	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 60	size: 1.1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416296/GSM1416296.CEL.gz	32321	1GSM1416297	mcgill.gq.315	GSE58644	GSE58644	GSM1416297	131	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 55	size: 3	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416297/GSM1416297.CEL.gz	32321	1GSM1416298	mcgill.gq.316	GSE58644	GSE58644	GSM1416298	112	event: 0	er: 0	her2: 1	grade: 2	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 73	size: 2.2	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416298/GSM1416298.CEL.gz	32321	1GSM1416299	mcgill.gq.317	GSE58644	GSE58644	GSM1416299	49	event: 0	er: 1	her2: 0	grade: 2	Stage: 2	lymph: 1	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 1	tamoxifen: 1	herceptin: NA	age: 56	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416299/GSM1416299.CEL.gz	32321	1GSM1416300	mcgill.gq.318	GSE58644	GSE58644	GSM1416300	66	event: 0	er: 1	her2: 1	grade: 3	Stage: 2	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: NA	age: 55	size: 3.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416300/GSM1416300.CEL.gz	32321	1GSM1416301	mcgill.gq.319	GSE58644	GSE58644	GSM1416301	104	event: 0	er: 1	her2: 0	grade: NA	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 77	size: 1.5	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416301/GSM1416301.CEL.gz	32321	1GSM1416302	mcgill.gq.320	GSE58644	GSE58644	GSM1416302	129	event: 0	er: 1	her2: 1	grade: 1	Stage: 1	lymph: 0	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: 1	herceptin: NA	age: 65	size: 1	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416302/GSM1416302.CEL.gz	32321	1GSM1416303	mcgill.gq.321	GSE58644	GSE58644	GSM1416303	104	event: 0	er: 0	her2: 0	grade: 3	Stage: NA	lymph: NA	untreated|chemotherapy|hormonotherapy|endocrine|chemo.plus.hormono	chemo: 0	tamoxifen: NA	herceptin: NA	age: 58	size: 0.6	suderman.et.al: 1	GPL6244	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1416nnn/GSM1416303/GSM1416303.CEL.gz	32321	1